WE SUPPORT & FINANCE BIOTECH COMPANIES WHO DEVELOP DRUGS & DIAGNOSTICS FOR THE DISEASE ALS
Our deeply rooted belief is that entrepreneurship in combination with research will drive innovation. The most efficient and proven model, in which entrepreneurs can strive and are incentivized, is the venture capital model. As we are specialized in one disease, we bring in-depth knowledge and an international network to the table.
We invest globally, but our focus is on Europe and the US.
We are entrepreneurs and investors who have been involved in several biotech and pharma companies in the rare disease — and ALS space. We know what it takes to bring technologies to the market and make a return for our investors (impact as well as financial return).
The ALS Investment Fund is managed by SUNU Ventures BV, a Dutch limited company.
Qurit Alliance along with several service providers have supported the launch of the fund and will take one Advisory Board seat to represent the patient’s perspective.